Abstract: Small molecule inhibitors of salt inducible kinases (SIKs) are provided. In particular, compounds of formula (I), and tautomers, stereoisomers, pharmaceutically acceptable salts and solvates thereof are provided. Also provided are pharmaceutical compositions containing the compounds, methods of preparing the compounds, and methods of using the compounds for inhibiting SIKs, such as SIK1 and SIK2, and methods of treating diseases mediated by SIKs.

Abstract: Described are techniques for verifying host path detection. First information from a first data storage system is received indicating a first set of one or more hosts and, for each host in the first set, which one or more devices of a first device set of the first data storage system are accessible to said each host in the first set over one or more associated paths to the first data storage system. Second information and the first information are received at a second data storage system. First processing is performed at the second data system to determine whether each host included in the first information has successfully completed path detection with respect to a second device set for the second data storage system.